pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 10·1 min read
save

Nominee for HHS emergency response role has a history of questioning vaccines

Jul 10, 2026·read at STAT ↗RegulatoryNegative

Sean Kaufman has been selected by the administration to lead the Office of Assistant Secretary for Preparedness and Response, overseeing the nation’s reaction to public health emergencies and disasters.

In prior public statements, Kaufman expressed doubts about the infant hepatitis B vaccine and promoted a discredited link between vaccines and autism, raising concerns among health officials.

His confirmation hearing, chaired by Senate health leader Bill Cassidy, could become contentious, as Cassidy has publicly opposed proposals to delay the hepatitis B shot and may challenge Kaufman's vaccine‑skeptical views.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Nominee for key federal health role has a history of questioning vaccines”

read at STAT ↗
1,020 words · retrieved Jul 10
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Moderna, Inc.3LEADING
drugs
hepatitis B vaccine4Coronavirus Disease 2019 (COVID-19) vaccineCoronavirus Disease 2019 (COVID-19) vaccine 1
topics
Vaccine14Vaccines14mRNA Therapeutic3Hepatology

related stories

  • Aug 31A winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Sep 14After a brief storm of political headwinds, mRNA is back with strong momentumBioSpace
  • Jun 15Covid vaccination cut risk of adverse heart events, large study findsSTAT
  • 5d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Oct 1Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEOFierce Biotech